MSGERC Grand Rounds Webinar Series

 

Episode 10—Superficial Fungal Infections and Implantation Mycoses: What’s New?

Archived from 7/16/2024

Are you aware of the recent emergence of resistant dermatophytosis in the United States? This includes the recent report of the first case of sexually-transmitted Trichophyton mentagrophytes Genotype VII (TMVII) in the United States. Do you know about CDC’s new research on implantation mycoses in the United States? Arm yourself with the knowledge you need to recognize and treat these fungal infections.

In this episode, experts in dermatology, pharmacy, infectious diseases, and public health address:

  • US and international perspectives on resistant dermatophyte infections, including risk factors, testing, resistance patterns, and pharmacologic management of resistant infections
  • US and international perspectives on the mode of transmission, epidemiology, differential diagnosis, and treatment of chromoblastomycosis, eumycetoma and sporotrichosis
  • New data from CDC on the epidemiology of resistant dermatophyte and implantation mycoses in the United States.

Faculty

Jeremy Gold, MD, MS

Medical Officer
Mycotic Diseases Branch
Centers for Disease Control and Prevention

Shari Lipner, MD, PhD

Associate Professor of Clinical Dermatology
Weill Cornell Medical College
New York, New York, USA

Flavio Queiroz-Telles, MD, PhD, FCMM

Public Health Department
Federal University of Parana
Curitiba, Brazil

Dallas Smith, PharmD

Epidemiologist
Mycotic Diseases Branch
US Centers for Disease Control and Prevention